Medscape Medical News
- Alert Clinical Trials of Venetoclax in Myeloma Stopped Due to Deaths
- Alert Ripple Effect: Repackaged Losartan Recalled Due to Impurity
- Alert FDA Warns of Mortality Signal With Paclitaxel Devices in PAD
- Alert FDA Warns About Serious Adverse Events With Surgical Staplers
- Alert FDA Okays Update of Problematic LifeVest Malfunction Alert
- Alert FDA Updates Sartan Recalls; Finds New Impurity
- Alert FDA Issues Class I Recall of Raindrop Near Vision Inlay Device
- Alert FDA Warns About Robotic Mastectomy, Other Surgeries
- Alert FDA Upgrades LIFEPAK 15 Monitor/Defibrillator Recall to Class I
- Alert Another Drug Company Recalls Tainted Losartan
- Alert FDA Warns Against Thermography for Breast Cancer Detection
- Alert FDA Warns of Risk for PE, Death With Higher Dose Xeljanz
- Alert Smoking Cessation Drug Not for Kids, FDA Says
- Alert FDA Warns of Higher Risk for Death With Gout Drug Febuxostat
- Alert Medtronic Recalls Pacemakers for Possible Circuit Error
- Alert FDA Panels Endorse Ketamine Spray for Resistant Depression
- Alert FDA Cracks Down on Illegal Sale of Alzheimer's 'Cures'
- Alert New European Rules to Eliminate Carcinogens in Sartans
- Alert Higher Than Expected Death Rate With Impella Heart Pump
- Alert Abuse-Deterrent OxyContin Tied to Spike in Hepatitis C